Accelix: Funding, Investors & Team (Sep 2026)
Accelix is a biotechnology company that helps cell and gene therapy companies to meet their key product QC requirements. It provides an instrument and a room temperature stable cartridge to gather multi-parameter results. The company was founded in 2007 and headquartered in Yerushalayim, Israel.
Accelix has raised $9.5M across 1 funding round on record, the most recent an undisclosed round of $9.5M announced in Jun 2020.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Accelix Company Profile and Key Stats
Latest funding round on record: Jun 2020.
Accelix Funding Rounds
Accelix Founders and Leadership Team
Contact details for the Accelix team: 1 of 1 has an email address on file.
Start 14-day free trial →Accelix Funding Compared to Other Biotechnology Startups
Accelix's latest round of $9.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Accelix in Biotechnology and Jerusalem
Companies Similar to Accelix
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also…
Magdent’s novel technology utilizes electromagnetic fields, PEMF technology, to stimulate, accelerate, and…
Brevel has created an innovative method of cultivating microalgae that is both sustainable and…
RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on…
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary…
IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for…
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing…
Phytolon is transforming the process of creating food colors by using an innovative and environmentally…
BlueWind Medical develops and markets a wireless neurostimulation device for the treatment of peripheral…
SuperMeat is an Israeli bio-tech and food-tech organization, fostering an innovation to make clean meat from…
ECOncrete technology provides sustainable solutions for construction of ecologically active infrastructures,…
MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for…
Accelix Funding FAQs
What does Accelix do?
Accelix is a biotechnology company that helps cell and gene therapy companies to meet their key product QC requirements. It provides an instrument and a room temperature stable cartridge to gather multi-parameter results. The company was founded in 2007 and headquartered in Yerushalayim, Israel.
How much funding has Accelix raised?
Accelix has raised $9.5M across 1 round on record. The most recent is an undisclosed round of $9.5M announced in Jun 2020.
When did Accelix last raise funding?
Accelix's most recent funding round on record is an undisclosed round of $9.5M, announced in Jun 2020.
Who is the CEO of Accelix?
Nir Nimrodi is listed as CEO at Accelix.
Where is Accelix headquartered?
Accelix is based in Jerusalem, Yerushalayim, Israel.
How many employees does Accelix have?
Accelix is in the 11-50 employee band.
How does Accelix's funding compare to other Biotechnology startups?
Accelix's latest round of $9.5M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Accelix Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Accelix is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.